• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TERT 启动子重复序列的保守特征揭示了一种激活机制,该机制模拟了癌症中的热点突变。

Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.

机构信息

Department of Neurological Surgery, University of California, San Francisco, CA, USA.

Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

出版信息

Nat Commun. 2022 Sep 16;13(1):5430. doi: 10.1038/s41467-022-33099-x.

DOI:10.1038/s41467-022-33099-x
PMID:36114166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9481613/
Abstract

Mutations in the TERT promoter represent the genetic underpinnings of tumor cell immortality. Beyond the two most common point mutations, which selectively recruit the ETS factor GABP to activate TERT, the significance of other variants is unknown. In seven cancer types, we identify duplications of wildtype sequence within the core promoter region of TERT that have strikingly similar features including an ETS motif, the duplication length and insertion site. The duplications recruit a GABP tetramer by virtue of the native ETS motif and its precisely spaced duplicated counterpart, activate the promoter and are clonal in a TERT expressing multifocal glioblastoma. We conclude that recurrent TERT promoter duplications are functionally and mechanistically equivalent to the hotspot mutations that confer tumor cell immortality. The shared mechanism of these divergent somatic genetic alterations suggests a strong selective pressure for recruitment of the GABP tetramer to activate TERT.

摘要

TERT 启动子中的突变代表了肿瘤细胞永生化的遗传基础。除了选择性招募 ETS 因子 GABP 来激活 TERT 的两个最常见的点突变外,其他变体的意义尚不清楚。在七种癌症类型中,我们在 TERT 的核心启动子区域内鉴定到野生型序列的重复,这些重复具有惊人的相似特征,包括 ETS 基序、重复长度和插入位点。这些重复通过天然的 ETS 基序及其精确间隔的重复对应物募集 GABP 四聚体,激活启动子,并在 TERT 表达的多灶性胶质母细胞瘤中呈克隆状态。我们得出结论,复发性 TERT 启动子重复在功能和机制上与赋予肿瘤细胞永生化的热点突变等效。这些不同的体细胞遗传改变的共同机制表明,强烈需要募集 GABP 四聚体来激活 TERT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/07e2f033d953/41467_2022_33099_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/12c77e88d743/41467_2022_33099_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/5c08dfc1de13/41467_2022_33099_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/cb3db3f6fcdd/41467_2022_33099_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/0d2cfc0d7362/41467_2022_33099_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/5afd2eafef0d/41467_2022_33099_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/07e2f033d953/41467_2022_33099_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/12c77e88d743/41467_2022_33099_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/5c08dfc1de13/41467_2022_33099_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/cb3db3f6fcdd/41467_2022_33099_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/0d2cfc0d7362/41467_2022_33099_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/5afd2eafef0d/41467_2022_33099_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac64/9481613/07e2f033d953/41467_2022_33099_Fig6_HTML.jpg

相似文献

1
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.TERT 启动子重复序列的保守特征揭示了一种激活机制,该机制模拟了癌症中的热点突变。
Nat Commun. 2022 Sep 16;13(1):5430. doi: 10.1038/s41467-022-33099-x.
2
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.β1L 异构体的 GABP 破坏以 TERT 启动子突变依赖性方式逆转胶质母细胞瘤复制性永生。
Cancer Cell. 2018 Sep 10;34(3):513-528.e8. doi: 10.1016/j.ccell.2018.08.003.
3
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.新的体细胞 TERT 启动子变异增强胶质母细胞瘤中的端粒酶活性。
Acta Neuropathol Commun. 2020 Aug 25;8(1):145. doi: 10.1186/s40478-020-01022-4.
4
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.癌症。转录因子GABP在癌症中选择性地结合并激活突变的端粒酶逆转录酶(TERT)启动子。
Science. 2015 May 29;348(6238):1036-9. doi: 10.1126/science.aab0015. Epub 2015 May 14.
5
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.GABP 将致癌基因信号与 TERT 启动子突变型癌症中的端粒调控偶联。
Cell Rep. 2022 Sep 20;40(12):111344. doi: 10.1016/j.celrep.2022.111344.
6
An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.一项关于TERT启动子复发性突变时转录因子结合的相互作用蛋白质组学研究。
Proteomics. 2016 Feb;16(3):417-26. doi: 10.1002/pmic.201500327. Epub 2016 Jan 8.
7
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.甲状腺癌中 TERT 启动子突变的频谱和激活机制。
Cancer Med. 2019 Oct;8(13):5831-5839. doi: 10.1002/cam4.2467. Epub 2019 Aug 13.
8
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.非经典NF-κB信号通路与ETS1/2协同驱动C250T突变型TERT启动子激活。
Nat Cell Biol. 2015 Oct;17(10):1327-38. doi: 10.1038/ncb3240. Epub 2015 Sep 21.
9
Understanding TERT Promoter Mutations: A Common Path to Immortality.了解端粒酶逆转录酶启动子突变:通往不朽的常见途径。
Mol Cancer Res. 2016 Apr;14(4):315-23. doi: 10.1158/1541-7786.MCR-16-0003. Epub 2016 Mar 3.
10
TERT promoter mutations in cancer development.癌症发展中的端粒酶逆转录酶(TERT)启动子突变
Curr Opin Genet Dev. 2014 Feb;24:30-7. doi: 10.1016/j.gde.2013.11.005. Epub 2013 Dec 20.

引用本文的文献

1
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.端粒酶逆转录酶(TERT)启动子突变型癌症的永生机制具有自我强化性且是可逆的。
Mol Cell. 2025 Jun 19;85(12):2337-2354.e9. doi: 10.1016/j.molcel.2025.05.026. Epub 2025 Jun 12.
2
Enhancer RNA-mediated transcriptional regulatory programs reveal the malignant progression of glioma.增强子RNA介导的转录调控程序揭示了胶质瘤的恶性进展。
Sci Adv. 2025 Jun 6;11(23):eadu9487. doi: 10.1126/sciadv.adu9487.
3
TERT Amplification a Risk Stratification Marker in Papillary Thyroid Carcinoma, Significantly Correlated with Tumor Recurrence and Survival.

本文引用的文献

1
Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer.TERT 启动子中特定等位基因 DNA 超甲基化的双重作用在癌症中的作用。
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI146915.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
Nuclear compartmentalization of TERT mRNA and TUG1 lncRNA is driven by intron retention.TERT mRNA 和 TUG1 lncRNA 的核区室化是由内含子保留驱动的。
端粒酶逆转录酶基因扩增作为甲状腺乳头状癌的风险分层标志物,与肿瘤复发和生存显著相关。
Endocr Pathol. 2025 Apr 24;36(1):15. doi: 10.1007/s12022-025-09853-4.
4
Mechanistic basis of atypical TERT promoter mutations.非典型 TERT 启动子突变的机制基础。
Nat Commun. 2024 Nov 18;15(1):9965. doi: 10.1038/s41467-024-54158-5.
5
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.评估全基因组测序在识别癌症基因组中驱动突变中的应用。
Sci Rep. 2024 Oct 12;14(1):23898. doi: 10.1038/s41598-024-74272-0.
6
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.端粒维持的机制及恶性脑胶质瘤相关的治疗弱点。
Neuro Oncol. 2024 Jun 3;26(6):1012-1024. doi: 10.1093/neuonc/noae016.
7
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.全肿瘤分析揭示了 TERT 启动子突变的早期起源和 TERT 表达的细胞间异质性。
Neuro Oncol. 2024 Apr 5;26(4):640-652. doi: 10.1093/neuonc/noad231.
8
Reactivation of telomerase reverse transcriptase expression in cancer: the role of TERT promoter mutations.端粒酶逆转录酶在癌症中的表达重新激活:TERT启动子突变的作用
Front Cell Dev Biol. 2023 Nov 15;11:1286683. doi: 10.3389/fcell.2023.1286683. eCollection 2023.
9
Cellular senescence in glioma.脑胶质瘤中的细胞衰老。
J Neurooncol. 2023 Aug;164(1):11-29. doi: 10.1007/s11060-023-04387-3. Epub 2023 Jul 17.
10
TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer.TONSL 是乳腺癌中的永生化癌基因和治疗靶点。
Cancer Res. 2023 Apr 14;83(8):1345-1360. doi: 10.1158/0008-5472.CAN-22-3667.
Nat Commun. 2021 Jun 3;12(1):3308. doi: 10.1038/s41467-021-23221-w.
4
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.新的体细胞 TERT 启动子变异增强胶质母细胞瘤中的端粒酶活性。
Acta Neuropathol Commun. 2020 Aug 25;8(1):145. doi: 10.1186/s40478-020-01022-4.
5
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.分析 2658 个癌症全基因组中的非编码体细胞驱动因子。
Nature. 2020 Feb;578(7793):102-111. doi: 10.1038/s41586-020-1965-x. Epub 2020 Feb 5.
6
Longitudinal molecular trajectories of diffuse glioma in adults.成人弥漫性神经胶质瘤的纵向分子轨迹。
Nature. 2019 Dec;576(7785):112-120. doi: 10.1038/s41586-019-1775-1. Epub 2019 Nov 20.
7
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.甲状腺癌中 TERT 启动子突变的频谱和激活机制。
Cancer Med. 2019 Oct;8(13):5831-5839. doi: 10.1002/cam4.2467. Epub 2019 Aug 13.
8
High-grade Adenocarcinoma of the Prostate Mimicking Urothelial Carcinoma is Negative for TERT Mutations.酷似尿路上皮癌的前列腺高级别腺癌TERT突变呈阴性。
Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):523-528. doi: 10.1097/PAI.0000000000000588.
9
Evolutionary Trajectories of IDH Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.IDH 胶质母细胞瘤的进化轨迹揭示了一种常见的早期肿瘤发生途径,其起始时间早于初始诊断数年。
Cancer Cell. 2019 Apr 15;35(4):692-704.e12. doi: 10.1016/j.ccell.2019.02.007. Epub 2019 Mar 21.
10
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.TERT 启动子内的 DNA 高甲基化上调了癌症中的 TERT 表达。
J Clin Invest. 2019 Jan 2;129(1):223-229. doi: 10.1172/JCI121303. Epub 2018 Dec 3.